Exabis Library
Welcome to the e-CCO Library!
P248: The diagnostic accuracy of Intestinal ultrasound for assessing disease activity in the proximal ileum and jejunum in children with Crohn's disease: Preliminary results of a prospective study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P248: The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P249 Use of a point-of-care screening tool to identify depression and anxiety in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P249: Clinical significance of endoscopic mucosal healing in patients with ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P249: Colonic Explant Lactate Concentration and Disease Progression in Ulcerative Colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P249: Endoscopic score vs. faecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P249: Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P249: Usefulness of abdominal ultrasonography for patency assessment using the patency capsule
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P249: Validation of a Novel Integral Disease Index (NIDI) for evaluating the grade of activity in Mexican patients with ulcerative colitis: a prospective cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P249: What’s the role of anti-TNF α in correcting anemia in Crohn’s disease?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P250 Root cause analysis to identify missed opportunities for the diagnosis of colorectal cancer in inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P250: Clinical validation of a point of care test for fecal calprotectin in distinguishing irritable bowel syndrome from Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P250: Does Ethnicity Influence Patient’s Preferences for Treatment Outcome? The Israeli Experience
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P250: DUBLIN (Degree of Ulcerative Colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P250: Frequency of extraintestinal manifestation in the early signs and symptoms of inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P250: The impact of Primary Sclerosing Cholangitis (PSC) on fecal calprotectin assessment in individuals with Inflammatory Bowel Disease (IBD)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P250: Use of complementary and alternative medicine is associated with chronic fatigue and lower health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis: results from the IBSEN study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P251 Small bowel capsule endoscopy is a valuable diagnostic tool in isolated terminal ileitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P251: Antiphospholipid antibodies in Crohn's disease: Results of a prospective single-center study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM